Table 1.5.
Company | Large Company | Acquisition cost (billion US$) | Year |
---|---|---|---|
GlycArt | Roche | 0.2 | 2005 |
Bioren | Pfizer | Undisclosed | 2005 |
Abgenix | Amgen | 2.2 | 2006 |
CAT | AstraZeneca | 1.3 | 2006 |
Zenyth | CSL | 0.1 | 2006 |
Abmaxis | Merck | 0.08 | 2006 |
NeuTec | Novartis | 0.6 | 2006 |
Rinat | Pfizer | 0.5 | 2006 |
Domantis | GSK | 0.5 | 2006 |
Morphotek | Eisai | 0.3 | 2007 |
THP | Roche | 0.06 | 2007 |
Tanox | Genentech | 0.9 | 2007 |
MedImmune | AstraZeneca | 15.6 | 2007 |